Endovia Health Sciences Files S-1 for Nasdaq IPO
Endovia Health Sciences, a medical technology company developing an AI-powered gynecological endoscopy diagnostic platform, filed its S-1 registration with the SEC on October 27, 2026, launching its Nasdaq IPO process. The company has not yet generated commercial revenue and relies primarily on private funding.
51CFO view：For digital health startups, the CFO must align FDA regulatory milestones with financial modeling—quantifying clinical delay risks in cash flow forecasts, applying ASC 606 rigorously to SaaS-like licensing revenue, and designing SOX 404(a)-compliant controls over PHI-secured cloud infrastructure.
Endovia Health Sciences, a medical technology company developing an AI-powered gynecological endoscopy diagnostic platform, filed its S-1 registration with the SEC on October 27, 2026, launching its Nasdaq IPO process. The company has not yet generated commercial revenue and relies primarily on private funding.
Source：SEC EDGAR · S-1 招股书备案
Why this matters to your CFO search
Where this touches your finance hire
Every listing event changes what you need from a CFO. Start from the step you are actually at.
What kind of CFO does a US IPO need?
S-1 / F-1 filing, US GAAP conversion, roadshow — the hard requirements.
Read →
Who owns SEC reporting and US GAAP?
Signature responsibility for 10-K / 10-Q / 8-K / 20-F, and common comments.
Read →
Who runs finance through a SPAC merger?
De-SPAC files F-1 / 424(b); merger audit and disclosure cadence differ.
Read →